
    
      Our Hypothesis is that the graft-versus-tumor effect can be enhanced while minimizing the
      complications of GVHD by determining the qualitative and quantitative changes in T regulatory
      cells throughout the transplant process. Our understanding of this can lead to new treatment
      strategies and improved clinical therapeutic implications.
    
  